The response of c-Jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1α dependent

Molecular and Cellular Biology

Volumn 22, Issue 8, 2002, Pages 2515-2523

  Laderoute, Keith R ^a   Calaoagan, Joy M ^a   Gustafson Brown, Cindy ^a   Knapp, A Merrill ^a   Li, Guo Chun ^a   Mendonca, Holly L ^a   Ryan, Heather E ^a   Wang, Zhaohui ^a   Johnson, Randall S ^a  

^a SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; SERINE; STRESS ACTIVATED PROTEIN KINASE; THREONINE; TRANSCRIPTION FACTOR AP 1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HYPOXIA; INFARCTION; MOUSE; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; STRESS; STROKE;

ANIMALS; BINDING SITES; CELL HYPOXIA; CELL LINE; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036210708     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.8.2515-2523.2002     Document Type: Article

References (76)

1. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells
2. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription
3. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1
4. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
5. Regulation of c-jun expression during hypoxic and low-glucose stress
6. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts
7. Cell cycledependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression
8. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types
9. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK
10. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
11. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells
12. Suppression of oncogene-induced transformation by a deletion mutant of c-jun
13. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation
14. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors
15. Epidermal growth factor induction of the c-jun promoter by a Rac pathway
16. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation
17. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK
18. Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells
19. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells
20. B-ATF: A novel human bZIP protein that associates with members of the AP-1 transcription factor family
21. Detection of hypoxia in human squamous cell carcinoma by EF5 binding
22. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
23. CBP/p300 in cell growth, transformation, and development
24. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function
25. Cre recombinase mediated alterations of the mouse genome using embryonic stem cells
26. Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell
27. 2 sensing
28. 2-regulated prolyl hydroxylation
29. 2 tension
30. Cellular transformation and malignancy induced by ras require c-jun
31. AP-1 function and regulation Curr
32. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
33. Suppression of tumor growth through disruption of hypoxia-inducible transcription
34. c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells
35. Early responses of SiHa human squamous carcinoma cells to hypoxic signals: Evidence of parallel activation of NF-kB and AP-1 transcriptional complexes
36. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity
37. Enhancement of transforming growth factor-alpha synthesis in multicellular tumor spheroids of A431 squamous carcinoma cells
38. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: Coordinate regulation with c-fos or c-myc
39. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
40. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation
41. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation
42. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity
43. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
44. Activation of the HIF pathway in cancer
45. Regulation and function of the JNK subgroup of MAP kinases
46. c-Jun gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells
47. Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway
48. c-Jun and p53 activity is modulated by SUMO-1 modification
49. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases
50. Production of completely ES-cell derived fetuses
51. 2-responsive sequences on the tyrosine hydroxylase gene
52. Post-translational control of the MEF2A transcriptional regulatory protein
53. Production of chimeras and genetically defined offspring from targeted ES cells
54. Intramolecular signal transduction in c-Jun
55. Glycogen synthase kinase-3: Functions in oncogenesis and development
56. Jun: Transcription factor and oncoprotein
57. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
58. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1
59. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-κB
60. HIF-1 alpha is required for solid tumor formation and embryonic vascularization
61. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth
62. Induction of protooncogene c-jun by serum growth factors
63. HIF-1 and mechanisms of hypoxia sensing
64. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
65. Transcriptional coactivators potentiating AP-1 function in bone
66. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines
67. Predictive power of the tumor oxygenation status
68. 2 tension
69. Induction and nuclear accumulation of Fos and Jun proto-oncogenes in hypoxic cardiac myocytes
70. Mammalian oxygen sensing, signalling and gene regulation
71. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
72. AP-1: One switch for many signals
73. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
74. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells
75. Hypoxia-associated induction of early growth response-1 gene expression
76. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia